Anja Hoffmann

发表

In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients

B. Gulyás, R. Boellaard, A. Lammertsma, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Parametric Binding Images of the TSPO Ligand 18F-DPA-714

R. Boellaard, A. Lammertsma, R. Schuit, 2016, The Journal of Nuclear Medicine.

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

John Seibyl, Yasuomi Ouchi, Ana M. Catafau, 2015, Alzheimer's & Dementia.

Quanti fi cation of [ 18 F ] DPA-714 binding in the human brain : initial studies in healthy controls and Alzheimer ’ s disease patients

R. Boellaard, A. Lammertsma, R. Schuit, 2015 .

ORIGINAL ARTICLE Quantification of ( 18 F)DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients

R. Boellaard, A. Lammertsma, R. Schuit, 2015 .

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

B. Gulyás, C. Rowe, C. Halldin, 2013, EJNMMI Research.

Cerebellar amyloid-beta plaques: How frequent are they, and do they influence 18 F-Florbetaben SUVR?

J. Seibyl, B. Ghetti, O. Sabri, 2016 .

Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.

N. Derichs, F. Vermeulen, J. Davies, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Edinburgh Research Explorer Cerebellar amyloid-beta plaques: How frequent are they, and do they influence 18F-Florbetaben SUVR?

J. Seibyl, B. Ghetti, O. Sabri, 2016 .

Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women

I. Gashaw, B. Rohde, J. Höchel, 2019, Reproductive Sciences.

Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain

S. McMahon, R. Treede, L. Hummelshoj, 2021, Pain.

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

E. Rabiner, C. Halldin, V. Oikonen, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study

John Seibyl, Ana M Catafau, Henryk Barthel, 2016, The Journal of Nuclear Medicine.

Cerebellar Amyloid-β Plaques: How Frequent Are They, and Do They Influence 18F-Florbetaben SUV Ratios?

Osama Sabri, Ana M Catafau, Bernardino Ghetti, 2016, The Journal of Nuclear Medicine.

Multicentre phase 3 trial on florbetaben for beta-amyloid brain PET in Alzheimer's disease

M. Sabbagh, J. Seibyl, B. Ghetti, 2012, Alzheimer's & Dementia.

Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients

R. Boellaard, A. Lammertsma, R. Schuit, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Comprehensive quantitative sensory testing shows altered sensory function in women with chronic pelvic pain: results from the Translational Research in Pelvic Pain (TRiPP) Study

S. McMahon, R. Treede, L. Arendt-Nielsen, 2023, Pain.

Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study

B. Gulyás, C. Halldin, A. Varrone, 2011, European Journal of Nuclear Medicine and Molecular Imaging.